Comparison of DSM-II and DSM-III schizophrenics: a longitudinal perspective

Area of Science:

• Psychiatry
• Clinical Psychology
• Mental Health Research

Background:

• Diagnostic criteria for schizophrenia have evolved, notably with the introduction of the DSM-III.
• Understanding how different diagnostic criteria affect patient outcomes is crucial for clinical practice and research.

Purpose of the Study:

• To compare patients diagnosed with schizophrenia based on DSM-III criteria versus those meeting DSM-II but not DSM-III criteria.
• To assess differences in positive symptoms, negative symptoms, and social competence between these diagnostic groups.
• To evaluate the stability and predictive power of these symptoms over a 7-year follow-up period.

Main Methods:

• A comparative study of patients diagnosed with schizophrenia using DSM-III versus DSM-II criteria.
• Assessment of positive symptoms, negative symptoms, and social competence at baseline and during a 7-year follow-up.
• Statistical analysis to determine significant differences and predictive relationships.

Main Results:

• Positive symptoms were the only significant differentiator at initial assessment, being more prevalent in the DSM-III group.
• Positive symptoms demonstrated greater stability and predictive value for patients meeting DSM-III criteria.
• Negative symptoms were the most stable and predictive variable for patients meeting DSM-II criteria.
• Increased homogeneity among DSM-III schizophrenics was not consistently observed across most measures.

Conclusions:

• The diagnostic criteria for schizophrenia (DSM-II vs. DSM-III) are associated with differential symptom profiles and trajectories.
• Positive symptoms appear more characteristic and stable in DSM-III defined schizophrenia, whereas negative symptoms are more predictive in DSM-II defined cases.
• Further research is needed to understand the clinical implications of these diagnostic distinctions and their impact on long-term outcomes.